| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHOPHT.1997.01100150377011 |
| P698 | PubMed publication ID | 9076211 |
| P2093 | author name string | D Johnson | |
| F Hoffmann | |||
| E Lütjen-Drecoll | |||
| R Futa | |||
| C Flügel | |||
| J Gottanka | |||
| P433 | issue | 3 | |
| P304 | page(s) | 375-383 | |
| P577 | publication date | 1997-03-01 | |
| P1433 | published in | JAMA Ophthalmology | Q4787301 |
| P1476 | title | Ultrastructural changes in the trabecular meshwork of human eyes treated with corticosteroids | |
| P478 | volume | 115 |
| Q90598589 | A review of systemic medications that may modulate the risk of glaucoma |
| Q90140202 | Activation of αvβ3 Integrin Alters Fibronectin Fibril Formation in Human Trabecular Meshwork Cells in a ROCK-Independent Manner |
| Q94415937 | An imaged-based inverse finite element method to determine in-vivo mechanical properties of the human trabecular meshwork |
| Q28085360 | Animal models of glucocorticoid-induced glaucoma |
| Q36863008 | Bioengineered glaucomatous 3D human trabecular meshwork as an in vitro disease model |
| Q49445957 | Biomechanical Rigidity and Quantitative Proteomics Analysis of Segmental Regions of the Trabecular Meshwork at Physiologic and Elevated Pressures. |
| Q47151506 | Concurrent injection of dexamethasone intravitreal implant and anti-angiogenic agent in patients with macular edema: A retrospective cohort study |
| Q33821262 | Corticosteroids and glaucoma risk |
| Q38266837 | Could mineralocorticoids play a role in the pathophysiology of open angle glaucoma? |
| Q33938206 | Development of a gene therapy virus with a glucocorticoid-inducible MMP1 for the treatment of steroid glaucoma |
| Q35870345 | Dexamethasone Stiffens Trabecular Meshwork, Trabecular Meshwork Cells, and Matrix |
| Q31135594 | Dexamethasone alters F-actin architecture and promotes cross-linked actin network formation in human trabecular meshwork tissue |
| Q40672130 | Dexamethasone regulates endothelin-1 and endothelin receptors in human non-pigmented ciliary epithelial (HNPE) cells |
| Q42502874 | Differential response and withdrawal profile of glucocorticoid-treated human trabecular meshwork cells |
| Q33706025 | Effects of glucocorticoids on the trabecular meshwork: towards a better understanding of glaucoma |
| Q40594680 | Elevated intraocular pressure associated with steroid treatment for infantile spasms |
| Q28207484 | Expression of optineurin, a glaucoma-linked gene, is influenced by elevated intraocular pressure |
| Q36646381 | Extracellular matrix in the trabecular meshwork |
| Q36035015 | Fluorescent protein-labeled glucocorticoid receptor alpha isoform trafficking in cultured human trabecular meshwork cells |
| Q40827200 | Functional morphology of the trabecular meshwork in primate eyes |
| Q37060277 | Gene therapy strategies in glaucoma and application for steroid-induced hypertension |
| Q90719304 | Generating cell-derived matrices from human trabecular meshwork cell cultures for mechanistic studies |
| Q37527287 | Genetically increasing Myoc expression supports a necessary pathologic role of abnormal proteins in glaucoma |
| Q52663098 | Glaucomatous cell derived matrices differentially modulate non-glaucomatous trabecular meshwork cellular behavior. |
| Q38889124 | Glucocorticoid therapy and ocular hypertension |
| Q92146655 | Identification of Gene Changes Induced by Dexamethasone in the Anterior Segment of the Human Eye Using Bioinformatics Analysis |
| Q33326842 | Immunohistochemical evaluation of the extracellular matrix in trabecular meshwork in steroid-induced glaucoma |
| Q44560624 | Increased synthesis and deposition of extracellular matrix proteins leads to endoplasmic reticulum stress in the trabecular meshwork |
| Q36880023 | Inducible scAAV2.GRE.MMP1 lowers IOP long-term in a large animal model for steroid-induced glaucoma gene therapy |
| Q33795569 | Inhaled corticosteroids, family history, and risk of glaucoma |
| Q52658376 | Intraocular Pressure Increases After Intraarticular Knee Injection With Triamcinolone but Not Hyaluronic Acid. |
| Q38938835 | Life under pressure: The role of ocular cribriform cells in preventing glaucoma |
| Q34512886 | Locally administered ocular corticosteroids: benefits and risks |
| Q34022583 | Morphologic changes in the outflow pathways of bovine eyes treated with corticosteroids |
| Q35131549 | Mutant myocilin nonsecretion in vivo is not sufficient to cause glaucoma |
| Q34768697 | Myocilin and glaucoma: facts and ideas. |
| Q47954026 | Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis. |
| Q36124051 | OCT Study of Mechanical Properties Associated with Trabecular Meshwork and Collector Channel Motion in Human Eyes |
| Q37726620 | Ocular-specific ER stress reduction rescues glaucoma in murine glucocorticoid-induced glaucoma |
| Q37608315 | Outcome of primary trabeculotomy ab interno (Trabectome) surgery in patients with steroid-induced glaucoma |
| Q36827557 | Overexpression of SPARC in human trabecular meshwork increases intraocular pressure and alters extracellular matrix |
| Q95803127 | Post-Vitrectomy Endophthalmitis in Victoria, Australia |
| Q28578850 | Proteomic analysis of rat retina in a steroid-induced ocular hypertension model: potential vulnerability to oxidative stress |
| Q43795356 | Rimexolone-induced intraocular pressure elevation |
| Q36354205 | Risk of Ocular Hypertension in Adults with Noninfectious Uveitis |
| Q38963936 | Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine |
| Q74028677 | Suppression of croton oil-induced rabbit corneal edema by sideritis javalambrensis |
| Q73066003 | Synthesis pattern of matrix metalloproteinases (MMPs) and inhibitors (TIMPs) in human explant organ cultures after treatment with latanoprost and dexamethasone |
| Q27321772 | TRPV4 regulates calcium homeostasis, cytoskeletal remodeling, conventional outflow and intraocular pressure in the mammalian eye. |
| Q38761425 | The Pathway From Genes to Gene Therapy in Glaucoma: A Review of Possibilities for Using Genes as Glaucoma Drugs |
| Q38263876 | The Trabecular Meshwork: A Basic Review of Form and Function |
| Q31127095 | Tissue plasminogen activator in trabecular meshwork attenuates steroid induced outflow resistance in mice |
| Q45070987 | Trabeculotomy ab interno with Trabectome as surgical management for systemic fluoroquinolone-induced pigmentary glaucoma: A case report |
| Q54979452 | Transforming growth factor β2 (TGFβ2) signaling plays a key role in glucocorticoid-induced ocular hypertension. |
| Q36620648 | Triamcinolone acetonide decreases outflow facility in C57BL/6 mouse eyes |
| Q34020747 | Ultrastructural changes associated with dexamethasone-induced ocular hypertension in mice. |
| Q43225993 | Unique response profile of trabecular meshwork cells to the novel selective glucocorticoid receptor agonist, GW870086X. |
Search more.